scholarly article | Q13442814 |
P356 | DOI | 10.4061/2011/951403 |
P953 | full work available online at | http://downloads.hindawi.com/journals/jar/2011/951403.pdf |
http://downloads.hindawi.com/journals/jar/2011/951403.xml | ||
https://downloads.hindawi.com/journals/jar/2011/951403.pdf | ||
https://europepmc.org/articles/PMC3134253 | ||
https://europepmc.org/articles/PMC3134253?pdf=render | ||
P932 | PMC publication ID | 3134253 |
P698 | PubMed publication ID | 21766035 |
P5875 | ResearchGate publication ID | 51499221 |
P50 | author | Dimitrios Adamis | Q43279412 |
P2093 | author name string | David Meagher | |
P2860 | cites work | The Journal of Clinical Endocrinology and Metabolism | Q3186902 |
Canadian Medical Association Journal | Q5030320 | ||
Predicting delirium in elderly patients: development and validation of a risk-stratification model | Q71592255 | ||
A half-century of delirium research: time to close the gap | Q72191502 | ||
The occurrence and duration of symptoms in elderly patients with delirium | Q72789896 | ||
Serum insulin-like growth factor I in a random population sample of men and women: relation to age, sex, smoking habits, coffee consumption and physical activity, blood pressure and concentrations of plasma lipids, fibrinogen, parathyroid hormone an | Q72792393 | ||
Insulin-like growth factor-1 inhibition of apoptosis is associated with increased expression of the bcl-xL gene product | Q73106933 | ||
Insulin-like growth factor I and interleukin-6 contribute synergistically to disability and mortality in older women | Q73344551 | ||
Psychiatric manifestations accompanying interferon therapy for patients with chronic hepatitis C: An overview of cases in Japan | Q73745527 | ||
Association of IGF-I levels with muscle strength and mobility in older women | Q74494165 | ||
Immunology of delirium: new opportunities for treatment and research | Q74582057 | ||
Transcriptional regulation of insulin-like growth factor-I by interferon-gamma requires STAT-5b | Q79191173 | ||
Frailty and the biochemical effects of recombinant human growth hormone in women after surgery for hip fracture | Q79304459 | ||
Pre-operative inflammatory markers and the risk of postoperative delirium in elderly patients | Q81280727 | ||
More attention, less confusion: time to lessen the burden of delirium | Q83358269 | ||
Delirium accelerates cognitive decline in Alzheimer disease | Q24650202 | ||
The Journal of the Association of Physicians of India | Q27711389 | ||
A new progeroid syndrome reveals that genotoxic stress suppresses the somatotroph axis | Q28280037 | ||
Serum insulin-like growth factor-1 in centenarians: implications of IGF-1 as a rapid turnover protein | Q32049225 | ||
Cerebrospinal fluid cortisol levels are higher in patients with delirium versus controls | Q33533964 | ||
Update on the neuropathogenesis of delirium | Q33726603 | ||
Insulin-like growth factors-I and -II differentially regulate endogenous acetylcholine release from the rat hippocampal formation | Q33744136 | ||
Validity of the confusion assessment method in detecting postoperative delirium in the elderly. | Q33815073 | ||
Actions and interactions of the IGF system in Alzheimer's disease: review and hypotheses | Q33884861 | ||
Does the insulin-like growth factor system interact with prostaglandins and proinflammatory cytokines during neurodegeneration? | Q33899264 | ||
Prevalence and detection of delirium in elderly emergency department patients | Q33954884 | ||
Multiple signaling pathways of the insulin-like growth factor 1 receptor in protection from apoptosis | Q33959860 | ||
Toward a comprehensive neurobiology of IGF-I. | Q34100780 | ||
Which medications to avoid in people at risk of delirium: a systematic review | Q34149090 | ||
The natural history of delirium in older hospitalized patients: a syndrome of heterogeneity | Q52001535 | ||
A long-term follow-up study of cerebrospinal fluid somatostatin in delirium | Q52026807 | ||
Age-sensitive cognitive function, growth hormone and insulin-like growth factor 1 plasma levels in healthy older men. | Q52029699 | ||
Delirium. The occurrence and persistence of symptoms among elderly hospitalized patients | Q52045518 | ||
Roles of growth hormone and insulin-like growth factor 1 in mouse postnatal growth | Q52142765 | ||
N-terminal tripeptide of IGF-1 (GPE) prevents the loss of TH positive neurons after 6-OHDA induced nigral lesion in rats | Q52170046 | ||
Precipitating factors for delirium in hospitalized elderly persons. Predictive model and interrelationship with baseline vulnerability | Q52308062 | ||
Insulin-like growth factors and insulin-like growth factor binding proteins in cerebrospinal fluid and serum of patients with dementia of the Alzheimer type | Q53201609 | ||
Abnormalities in adrenal androgens, but not of glucocorticoids, in early Alzheimer's disease | Q53203458 | ||
Decreased plasma insulin-like growth factor-I level in familial Alzheimer's disease patients carrying the Swedish APP 670/671 mutation | Q53231343 | ||
Protective and rescuing abilities of IGF-I and some putative free radical scavengers against beta-amyloid-inducing toxicity in neurons. | Q53232949 | ||
The ratio between serum levels of insulin-like growth factor (IGF)-I and the IGF binding proteins (IGFBP-1, 2 and 3) decreases with age in healthy adults and is increased in acromegalic patients | Q57420747 | ||
The Prevalence of Dementia in Europe: A Collaborative Study of 1980–1990 Findings | Q57782178 | ||
Risk factors and incidence of postoperative delirium in elderly patients after elective and emergency surgery | Q58766619 | ||
Growth Factors Rescue Embryonic Dopamine Neurons from Programmed Cell Death | Q59741464 | ||
Insulin-Like Growth Factor-I and Cognitive Function in Healthy Older Men | Q60038410 | ||
Cytokines, insulin-like growth factor 1, sarcopenia, and mortality in very old community-dwelling men and women: the Framingham Heart Study | Q61663307 | ||
Insulin-Like Growth Factor-1 Inhibition of Apoptosis Is Associated with Increased Expression of the bcl-xL Gene Product | Q61774359 | ||
IGF1 as predictor of all cause mortality and cardiovascular disease in an elderly population | Q61793914 | ||
Insulin-like growth factors and subsequent risk of mortality in the United States | Q64128401 | ||
The relationship between insulin-like growth factor-I, adiposity, and aging | Q68812981 | ||
Somatomedins in aging and dementia disorders of the Alzheimer type | Q70491373 | ||
Delirium and dementia; are they distinct? | Q71260846 | ||
A cautionary note on the use of the TUNEL stain to determine apoptosis | Q71351155 | ||
Delirium in acute stroke: a predictor of subsequent cognitive impairment? A two-year follow-up study | Q51013235 | ||
Total insulinlike growth factor 1 and insulinlike growth factor binding protein levels, functional status, and mortality in older adults | Q51452772 | ||
Serum levels of insulin-like growth factor-I (IGF-I) and IGF-binding protein-3 in healthy centenarians: relationship with plasma leptin and lipid concentrations, insulin action, and cognitive function | Q51574767 | ||
Acute confusional states in elderly patients treated for femoral neck fracture | Q51771900 | ||
Cytokines and IGF-I in delirious and non-delirious acutely ill older medical inpatients | Q51778509 | ||
Relationship between cognitive status at admission and incident delirium in older medical inpatients | Q51843753 | ||
Ethical research in delirium: arguments for including decisionally incapacitated subjects | Q51871907 | ||
APOE and cytokines as biological markers for recovery of prevalent delirium in elderly medical inpatients | Q51908263 | ||
Recovery and outcome of delirium in elderly medical inpatients | Q51922042 | ||
6 Factors controlling blood concentration of somatomedin C | Q40109950 | ||
The neuropathogenesis of delirium. A need to focus our research | Q40625700 | ||
Effects of growth hormone and insulin-like growth factor I on the immune system | Q40938877 | ||
Growth factors improve immediate survival of embryonic dopamine neurons after transplantation into rats | Q41033079 | ||
Critically ill patients have high basal growth hormone levels with attenuated oscillatory activity associated with low levels of insulin-like growth factor-I. | Q41164502 | ||
Regulation of insulin-like growth factor I production in rat C6 glioma cells: possible role as an autocrine/paracrine growth factor | Q41624581 | ||
Intrauterine growth retardation and postnatal growth failure associated with deletion of the insulin-like growth factor I gene | Q41927570 | ||
Acute confusion in elderly medical patients | Q42078551 | ||
Igf1 gene disruption results in reduced brain size, CNS hypomyelination, and loss of hippocampal granule and striatal parvalbumin-containing neurons | Q42484843 | ||
SirT1 inhibition reduces IGF-I/IRS-2/Ras/ERK1/2 signaling and protects neurons | Q42914852 | ||
Risk Factors for Delirium in Hospitalized Elderly | Q43498609 | ||
Growth hormone replacement in healthy older men improves body composition but not functional ability | Q43506669 | ||
Relationships between cortisol, dehydroepiandrosterone sulphate and insulin-like growth factor-I system in dementia | Q43583581 | ||
Insulin-like growth factors I and II in healthy man. Estimations of half-lives and production rates | Q43667170 | ||
Dexamethasone reduces steady state insulin-like growth factor I messenger ribonucleic acid levels in rat neuronal and glial cells in primary culture | Q43735018 | ||
Cytokines and acute phase response in delirium | Q43911607 | ||
IGF-I has a direct proliferative effect in adult hippocampal progenitor cells | Q44612681 | ||
The prospective association of serum insulin-like growth factor I (IGF-I) and IGF-binding protein-1 levels with all cause and cardiovascular disease mortality in older adults: the Rancho Bernardo Study | Q44723020 | ||
Growth hormone dependence of somatomedin-C/insulin-like growth factor-I and insulin-like growth factor-II messenger ribonucleic acids | Q44763831 | ||
Relationship between baseline insulin-like growth factor-I (IGF-I) and femoral bone density in women aged over 70 years: potential implications for the prevention of age-related bone loss | Q44846822 | ||
N-terminal tripeptide of IGF-1 improves functional deficits after 6-OHDA lesion in rats | Q44962348 | ||
The clinical profile and association of delirium in geriatric patients with hip fractures in a tertiary care hospital in India. | Q45216524 | ||
Insulin-like growth factor binding protein-3: insulin-like growth factor independence comes of age. | Q46695670 | ||
The effects of recombinant human insulin-like growth factor-I and growth hormone on body composition in elderly women | Q46972658 | ||
Association of insulin-like growth factor-I with body composition, weight history, and past health behaviors in the very old: the Framingham Heart Study | Q47315272 | ||
Do guidelines improve the process and outcomes of care in delirium? | Q47643402 | ||
Serum free IGF-I, total IGF-I, IGFBP-1 and IGFBP-3 levels in an elderly population: relation to age and sex steroid levels. | Q47926827 | ||
Cognitive changes during growth hormone replacement in adult men | Q47998114 | ||
Asphyxial brain injury--the role of the IGF system | Q48403241 | ||
Serum insulin-like growth factor I regulates brain amyloid-beta levels | Q48454367 | ||
Insulin-like Growth Factor-1 (IGF-1) Improves both Neurological Motor and Cognitive Outcome Following Experimental Brain Injury | Q48607091 | ||
Peripheral infusion of IGF-I selectively induces neurogenesis in the adult rat hippocampus. | Q49084529 | ||
Insulin-like growth factor-I and cognitive function in healthy older men. | Q49087051 | ||
Plasma insulin growth factor-1 and incident delirium in older people | Q49133122 | ||
Cytokine inhibition of JAK-STAT signaling: a new mechanism of growth hormone resistance | Q34368943 | ||
Tumor necrosis factor(alpha) and insulin-like growth factor-I in the brain: is the whole greater than the sum of its parts? | Q34390682 | ||
Use of growth hormone and growth hormone secretagogues in aging: help or harm. | Q34401224 | ||
Occurrence and outcome of delirium in medical in-patients: a systematic literature review | Q34519275 | ||
The course of delirium in older medical inpatients: a prospective study | Q34742312 | ||
Delirium risk factors in elderly hospitalized patients | Q34751734 | ||
Mutant mouse models of insulin-like growth factor actions in the central nervous system | Q34930598 | ||
Delirium superimposed on dementia: a systematic review | Q34941448 | ||
Potential roles of insulin and IGF-1 in Alzheimer's disease. | Q35192493 | ||
Capacity, consent, and selection bias in a study of delirium | Q35429196 | ||
Systemic inflammation induces acute working memory deficits in the primed brain: relevance for delirium. | Q35431528 | ||
Nutrition, insulin, insulin-like growth factors and cancer | Q35622485 | ||
An approach to drug induced delirium in the elderly | Q35836649 | ||
The association between delirium and cognitive decline: a review of the empirical literature | Q35841474 | ||
An evaluation of the role of insulin-like growth factors (IGF) and of type-I IGF receptor signalling in hepatocarcinogenesis and in the resistance of hepatocarcinoma cells against drug-induced apoptosis | Q35863982 | ||
Evidence for a link between IGF-I and cancer. | Q35875689 | ||
Insulin-like growth factor I protects and rescues hippocampal neurons against beta-amyloid- and human amylin-induced toxicity. | Q36146984 | ||
Regulation of insulin-like growth factor I gene expression by growth hormone | Q36458732 | ||
Regulation of muscle mass by growth hormone and IGF-I. | Q36736100 | ||
Defining normalcy of the somatotropic axis: an attainable goal? | Q36780865 | ||
Insulin-like growth factor-1 and delirium in critically ill mechanically ventilated patients: a preliminary investigation. | Q36845604 | ||
Participation in activity and risk for incident delirium | Q36953705 | ||
Impaired growth hormone secretion in the adult population: relation to age and adiposity | Q36998642 | ||
Hypercholesterolemia-induced Abeta accumulation in rabbit brain is associated with alteration in IGF-1 signaling | Q37135881 | ||
Defining delirium for the International Classification of Diseases, 11th Revision | Q37245360 | ||
Unravelling the pathophysiology of delirium: a focus on the role of aberrant stress responses | Q37245372 | ||
Insulin receptor dysfunction impairs cellular clearance of neurotoxic oligomeric a{beta} | Q37253971 | ||
Interleukin 6 causes growth impairment in transgenic mice through a decrease in insulin-like growth factor-I. A model for stunted growth in children with chronic inflammation | Q37363276 | ||
Delirium and long-term cognitive impairment | Q37393991 | ||
Insulin-like growth factor 1 regulates developing brain glucose metabolism | Q37438813 | ||
Immune modulation of learning, memory, neural plasticity and neurogenesis | Q37802555 | ||
The informed consent process in older patients who developed delirium: a clinical epidemiologic study | Q39456302 | ||
PI3K p110 alpha and p110 beta have differential effects on Akt activation and protection against oxidative stress-induced apoptosis in myoblasts | Q39634639 | ||
P275 | copyright license | Creative Commons Attribution 3.0 Unported | Q14947546 |
P6216 | copyright status | copyrighted | Q50423863 |
P407 | language of work or name | English | Q1860 |
P921 | main subject | delirium | Q160796 |
pathogenesis | Q372016 | ||
P304 | page(s) | 951403 | |
P577 | publication date | 2011-07-03 | |
P13046 | publication type of scholarly work | review article | Q7318358 |
P1433 | published in | Journal of Aging Research | Q26841941 |
P1476 | title | Insulin-like growth factor I and the pathogenesis of delirium: a review of current evidence | |
Insulin-Like Growth Factor I and the Pathogenesis of Delirium: A Review of Current Evidence | |||
P478 | volume | 2011 |
Q37682601 | Delirium and depression: inter-relationship and clinical overlap in elderly people |
Q87192348 | Delirium in the Nursing Home |
Q84421018 | Insulin-like growth factor 1 and delirium |
Q36932274 | Lack of Association between Pre-Operative Insulin-Like Growth Factor-1 and the Risk of Post-Operative Delirium in Elderly Chinese Patients |
Q38098921 | Obstructive sleep apnea and delirium: exploring possible mechanisms |
Q57193242 | Serum insulin-like growth factor 1 (IGF-1) in multiple sclerosis: relation to cognitive impairment and fatigue |
Q33996744 | The Association between IGF-1 Polymorphisms, IGF-1 Serum Levels, and Cognitive Functions in Healthy Adults: The Amsterdam Growth and Health Longitudinal Study |
Q38915805 | The Association of Serum Levels of Brain-Derived Neurotrophic Factor with the Occurrence of and Recovery from Delirium in Older Medical Inpatients. |
Q35108416 | The protocol of the Oslo Study of Clonidine in Elderly Patients with Delirium; LUCID: a randomised placebo-controlled trial |
Search more.